Evolve Insights

Welcome to Evolve Insights!

Evolve Insights is your go-to source for expert analysis and strategic perspectives on pharmaceutical IP.

Read our Articles for the latest pharma IP news and analysis. Many of our articles were originally published on IPKat.
Register for our upcoming live Webinars and watch our previous webinars on-demand.
Subscribe to our newsletter to stay up to date.

Do you have questions about how the latest developments in IP might impact you? Our team of experts would love to hear from you.

Latest articles

Be careful what you wish for: Method of treatment claim for an antibody genus found to satisfy both written description and enablement requirement (Teva v Eli Lilly)

3rd July 2026

In a remarkable departure from what we might have expected it to do following Amgen v Sanofi, the US Court of Appeals of the Federal Circuit in Teva v Eli Lilly upheld a jury verdict finding that a method of treatment claim for a broad genus of antibody satisfied both the written description and enablement…

Navigating the complex LNP IP landscape

1st July 2026

It is difficult to find a field of patent law in pharma and biotech at the moment that is more complicated and fast-moving than the field of lipid nanoparticles (LNPs). IP strategy for LNPs involves sophisticated science, multiple and overlapping technology platforms, trade secret and ownership disputes and global patent cross-litigation.

Alice Walford joins Evolve

1st July 2026

We are delighted to welcome Alice Walford to the Evolve team. Alice joins us with over 15 years of combined private practice and in-house experience in the life sciences sector. Alice brings a wealth of experience, including time at Novartis, Gyroscope Therapeutics and Abzena, working on gene therapies, small molecule and antibody assets. Her specialist…

Webinars

In person event

In-person event: Festive EPO pharma case law 2025 round-up

Upcoming date: December 17, 2025, 4:00 pm GMT

Join us for a wrap up review of the key pharma EPO caselaw in 2025 and a look ahead to 2026 alongside some mince pies and festive cheer.

On-demand

EPO pharma case law 2025: Everything you need to know!

Recorded on: December 12, 2025

Key pharma IP trends, landmark EPO decisions, and strategic advice for IP professionals.

On-demand

Securing return of investment: Understanding how large pharma companies think about IP

Recorded on: September 19, 2025

Learn how large pharmaceutical companies think about IP strategy.

Stay connected

Get the latest insights, news, and expert analysis on pharmaceutical IP delivered straight to your inbox.

PHARMACEUTICAL IP